JP2024539138A5 - - Google Patents
Info
- Publication number
- JP2024539138A5 JP2024539138A5 JP2024523623A JP2024523623A JP2024539138A5 JP 2024539138 A5 JP2024539138 A5 JP 2024539138A5 JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024523623 A JP2024523623 A JP 2024523623A JP 2024539138 A5 JP2024539138 A5 JP 2024539138A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- peptide
- amino acids
- peptide according
- side chains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21204274.1 | 2021-10-22 | ||
| EP21204274 | 2021-10-22 | ||
| PCT/EP2022/079429 WO2023067167A1 (en) | 2021-10-22 | 2022-10-21 | Peptides with multivalent effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539138A JP2024539138A (ja) | 2024-10-28 |
| JP2024539138A5 true JP2024539138A5 (enExample) | 2025-11-11 |
Family
ID=78592450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523623A Pending JP2024539138A (ja) | 2021-10-22 | 2022-10-21 | 多価効果を持つペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250313820A1 (enExample) |
| EP (1) | EP4419664A1 (enExample) |
| JP (1) | JP2024539138A (enExample) |
| CN (1) | CN118202043A (enExample) |
| AU (1) | AU2022369065A1 (enExample) |
| CA (1) | CA3233135A1 (enExample) |
| WO (1) | WO2023067167A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024223868A1 (en) * | 2023-04-26 | 2024-10-31 | In2Cure Ab | Peptides with multivalent effects for topical use |
| WO2025051955A1 (en) | 2023-09-06 | 2025-03-13 | In2Cure Ab | Materials with anti-inflammatory and/or anti-microbial properties |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1987056B1 (en) * | 2006-02-10 | 2012-07-25 | Dermagen AB | Novel antimicrobial peptides and use thereof |
| GB0916576D0 (en) * | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| AU2018304230A1 (en) | 2017-07-19 | 2020-02-06 | Dana-Farber Cancer Institute, Inc. | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections |
| JP7785001B2 (ja) * | 2019-12-18 | 2025-12-12 | イントゥーキュア エービー | トロンビン由来ペプチドを含む組成物およびその使用 |
-
2022
- 2022-10-21 US US18/702,831 patent/US20250313820A1/en active Pending
- 2022-10-21 AU AU2022369065A patent/AU2022369065A1/en active Pending
- 2022-10-21 CA CA3233135A patent/CA3233135A1/en active Pending
- 2022-10-21 WO PCT/EP2022/079429 patent/WO2023067167A1/en not_active Ceased
- 2022-10-21 CN CN202280070606.5A patent/CN118202043A/zh active Pending
- 2022-10-21 JP JP2024523623A patent/JP2024539138A/ja active Pending
- 2022-10-21 EP EP22809362.1A patent/EP4419664A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024539138A5 (enExample) | ||
| US11472842B2 (en) | Analogues of hepcidin mimetics with improved in vivo half lives | |
| US7348401B2 (en) | Peptides that inhibit complement activation | |
| JP2010535714A5 (enExample) | ||
| JP6095717B2 (ja) | Ｔｆｐｉインヒビターおよび使用法 | |
| JP2020502051A5 (enExample) | ||
| JP2015110662A (ja) | 長期間作用性ペプチド類似体のための組成物 | |
| JP2012067100A (ja) | Ｉｌ−２１の誘導体 | |
| JP6633523B2 (ja) | Ｐｓｄ−９５の二量体阻害剤脂肪酸誘導体 | |
| JP2020526497A5 (enExample) | ||
| AU2005232475A1 (en) | Novel g-csf conjugates | |
| TW202306965A (zh) | Ｐｓｄ－９５抑制劑及其用途 | |
| WO2022125606A2 (en) | Peptide therapeutics for treating alzheimer's disease and related conditions | |
| CN1867581B (zh) | Il-21衍生物 | |
| JP2016521258A5 (enExample) | ||
| AU5741794A (en) | Treatment of septic shock with conjugated biologically active peptides | |
| IL298980A (en) | C-type natriuretic peptides and methods thereof in treating acute lung injury | |
| US5358933A (en) | Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock | |
| JP2024539138A (ja) | 多価効果を持つペプチド | |
| JP3221881B2 (ja) | Ｃ反応性タンパク質断片から誘導されたオリゴペプチド | |
| JP2022513626A5 (enExample) | ||
| US20260028397A1 (en) | Methods of treating ankylosing spondylitis | |
| JPH09506863A (ja) | 血小板由来増殖因子アナログ | |
| WO2024164864A1 (zh) | 一种多肽及其用途 | |
| AU673332B2 (en) | Peptide which abrogates TNF and/or LPS toxicity |